4.8 Editorial Material

Illuminating spatial pharmacology with in situ drug imaging COMMENT

Related references

Note: Only part of the references are listed.
Article Biochemistry & Molecular Biology

In situ identification of cellular in mammalian tissue

Zhengyuan Pang et al.

Summary: This study develops a clearing-assisted tissue click chemistry (CATCH) technique for optically imaging covalent drug targets in intact mammalian tissues. The researchers find that CATCH enables specific and robust imaging of target-bound drug molecules at subcellular resolution, and it can also identify the target cell types. By using inhibitors of endocannabinoid hydrolases and monoamine oxidases, the study not only reveals distinct anatomical distributions and predominant cell targets of different drug compounds in the mouse brain, but it also uncovers unexpected differences in drug engagement across and within brain regions, reflecting rare cell types and dose-dependent target shifts that cannot be accessed by conventional methods.
Review Chemistry, Multidisciplinary

Direct Cell Radiolabeling for in Vivo Cell Tracking with PET and SPECT Imaging

Peter J. Gawne et al.

Summary: The arrival of cell-based therapies has revolutionized medicine. Radionuclide imaging, such as SPECT or PET, is a highly sensitive and quantitative imaging technique that has advantages for cell tracking. Direct cell radiolabeling, using a variety of chemical approaches, is a simple and reliable method for labeling cells without genetic modification.

CHEMICAL REVIEWS (2022)

Article Chemistry, Medicinal

10 years into the resurgence of covalent drugs

Elena De Vita

Summary: In the first decade of targeted covalent inhibition, scientists have made significant progress in reversing the previous trend that hindered the use of covalent inhibition in drug development, especially in the field of kinase inhibitors. The successful entry of KRAS(G12C) covalent inhibitors into clinical trials in 2019 has sparked great interest in the future potential of this area of drug discovery. Despite the achievements, there are still many unanswered questions and areas for improvement in terms of safety and effectiveness.

FUTURE MEDICINAL CHEMISTRY (2021)

Article Chemistry, Medicinal

Strategies for Structural Modification of Small Molecules to Improve Blood-Brain Barrier Penetration: A Recent Perspective

Baichen Xiong et al.

Summary: The blood-brain barrier poses challenges in delivering drugs to the brain, with small molecule drugs dominating current CNS medication. Medicinal chemists have been working on enhancing the penetration of small molecules by improving diffusion, reducing efflux, and activating carrier transporters, aiming to provide insights for future development of small molecule CNS drugs.

JOURNAL OF MEDICINAL CHEMISTRY (2021)

Review Biochemistry & Molecular Biology

Click Chemistry in Proteomic Investigations

Christopher G. Parker et al.

Review Biochemical Research Methods

Single-cell Proteomics: Progress and Prospects

Ryan T. Kelly

MOLECULAR & CELLULAR PROTEOMICS (2020)

Review Oncology

Understanding and targeting resistance mechanisms in NSCLC

Julia Rotow et al.

NATURE REVIEWS CANCER (2017)